Searched for
DESLORATADINE
Volatility is temporary, fundamental tailwinds are permanent: 5 mid-cap pharma stocks with an upside potential of up to 46%Official Action Indicated (OAI). Not many investors may have heard of this. But they would surely have felt its impact. For, the moment OAI...- Smallcaps with long term perspective; 4 stocks with right levels of RoE and upside potential of up to 41%The recent performance of small caps has brought them in the category of stocks where the desire to own them is “highest”. But the fact whi...
- For investors with risk appetite: 4 smallcap stocks with upside potential of up to 36%The risk on trade, which essentially means taking exposure to the riskier asset class started once again. In India, this meant that once ag...
- Morepen gets USFDA nod to market generic anti-allergy drugDrug firm Morepen Laboratories on Friday said it has received approval from the US health regulator to market its anti-allergy drug Fexofin...
- Sensex slips 100 points, Nifty below 8,450; Ramco Systems up 20%,The domestic markets were trading modestly lower. The S&P Sensex was testing 28,000 level. Nifty was struggling to hold the psychological m...
- Top 12 stocks in focus in Thursday's morning tradeAccording to technical analysts, the Nifty has potential to rally another 150 points once it manages to cross 8500 mark comfortably.
- Dr Reddy's launches generic antihistamine tablets in USDrug firm Dr Reddy's Laboratories today said it has launched generic antihistamine desloratadine tablets in the American market.
- Dr Reddy's expects North American biz to drive growth this FYDr Reddy's Laboratories expects generics business in North America to be its main growth driver this fiscal.
- Lupin gets FDA nod for anti-allergic tabletsDrug firm Lupin today said it has been granted final approval by the United states Food and Drug Administration for antihistamine Deslorata...
- Lupin gains 4% over drug patent settlementDrug maker Lupin rose over 4 per cent after the firm said it had settled a patent litigation with US-based Schering-Plough Corp relating to...
- Lupin declares litigation settlement with Schering-PloughLupin Ltd has settled all ongoing Hatch-Waxman litigation relating to desloratadine tablets, the generic version of Schering-Plough's Clari...
- Glenmark confirms Abbott suit against Tarka genericGlenmark Pharmaceuticals has confirmed that Abbott has filed a suit in the US District Court of New Jersey on December 7, seeking to preven...
- Sepracor spanner in Sun Pharma's US planUS-based drug giant Sepracor Inc and the University of Massachusetts have filed a patent infringement suit with the US district court of Ne...
Load More
